FDA Approves First Cell Therapy for Solid Tumors, Marking a Significant Milestone In a groundbreaking development, the U.S. Food and...
Breast cancer is one of the most common types of cancer affecting women worldwide. According to the World Health Organization...
Gilead Sciences, a leading biopharmaceutical company, has recently announced its plans to expand its investment in Arcus Biosciences and its...
An Overview of Genentech’s i-shaped Abs: A Bispecific Dendritic-T Cell Engager and Beyond Genentech, a leading biotechnology company, has been...
Understanding the Implications of Gilead’s Trodelvy Challenges and Elevation Oncology’s Unexpected Success In the world of oncology, the development and...
Title: FDA Warns of Rare Risk of Secondary Cancer Associated with CAR-T Therapies Introduction The U.S. Food and Drug Administration...
The NKG2D rs1049174 Polymorphism in Donors Predicts Hematopoietic Recovery and Event-Free Survival Following Single-Unit Cord Blood Transplantation in Adults: Insights...
The Food and Drug Administration (FDA) has recently mandated additional cancer warnings for Chimeric Antigen Receptor T-cell (CAR-T) therapies. This...
Title: Investigating the Correlation between Type 1 CALR Mutation Allele Frequency and CD34/CXCR4 Expression in Myelofibrosis-Type Megakaryocyte Dysplasia: Unraveling a...
The role of S100A8/A9 in promoting endometrial fibrosis through the regulation of RAGE/JAK2/STAT3 signaling pathway – Insights from Communications Biology...
The Food and Drug Administration (FDA) has recently approved a groundbreaking drug called Balversa (erdafitinib) for the treatment of FGFR3+...
Novartis, a leading pharmaceutical company, has recently released comprehensive information on the initial results of their radiopharmaceutical drug, Lutathera, as...
New EU Approval Granted to Roche’s Cancer Immunotherapy Roche, a leading pharmaceutical company, has recently received approval from the European...
New Developments in NSCLC Treatment: Strategies to Overcome Osimertinib Resistance Non-small cell lung cancer (NSCLC) is the most common type...
The Role of ROR2 Expression in Predicting Differentiation of Human Induced Pluripotent Stem Cells into Neural Stem/Progenitor Cells and GABAergic...
